Corbus Pharmaceuticals Holdings, Inc. Equity-NMS: CRBP

$6.43 0.37 (September 27, 2023)

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Previous close :$6.06
Open :$6.4
Today's high :$6.97
Today's low :$6.4
52W low :$2.11
52W high :$13.17
1Y :4107.95%
5Y :-8.27%
EPS(TTM): :-0.3711
Shares O/S :4.42 M
Market cap :28.44 M

Compare with Other Stocks

Frequently Asked Questions

What is the share price of Corbus Pharmaceuticals Holdings, Inc. today?

Corbus Pharmaceuticals Holdings, Inc. (CRBP) share price as of September 27, 2023, is $6.43. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Corbus Pharmaceuticals Holdings, Inc.?

Yes, Indian Investors can invest in the Corbus Pharmaceuticals Holdings, Inc. (CRBP) Share by opening an international trading account with Angel One.

How can I purchase Corbus Pharmaceuticals Holdings, Inc. shares in India?

Purchasing Corbus Pharmaceuticals Holdings, Inc. (CRBP) share from India can be done by:
  1. Directly: By opening an international trading account with Angel One. The process would include KYC verification.
    The account activation takes a few minutes to a few hours, after which you can start buying Corbus Pharmaceuticals Holdings, Inc. (CRBP) by making deposits in US dollars.
  2. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Corbus Pharmaceuticals Holdings, Inc.?

Yes, you can purchase fractional shares of Corbus Pharmaceuticals Holdings, Inc. (CRBP) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Corbus Pharmaceuticals Holdings, Inc.?

The market capitalization of Corbus Pharmaceuticals Holdings, Inc. on September 27, 2023, is $28.44 M.

In which sector Corbus Pharmaceuticals Holdings, Inc. belongs?

Corbus Pharmaceuticals Holdings, Inc. operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in Corbus Pharmaceuticals Holdings, Inc. stocks?

In order to invest in Corbus Pharmaceuticals Holdings, Inc. (CRBP) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

About Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Holdings, Inc. is a precision oncology company. The Company is engaged in developing and commercializing therapeutics for autoimmunity, fibrosis, and cancer. Its internal development pipeline includes CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, and CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFβ expressed on cancer cells. It has developed CRB-913, a second-generation cannabinoid receptor type 1 (CB1) inverse agonist designed to treat obesity and related metabolic diseases. The CRB-913 program is in the pre-clinical-stage. It also includes Lenabasum, which is a novel, synthetic, oral molecule that selectively activates cannabinoid receptor type 2 (CB2) for the treatment of inflammation and fibrosis. Its subsidiaries include Corbus Pharmaceuticals, Inc., Corbus International Limited and Corbus Pharmaceuticals Australia Pty Ltd.